ethinyl estradiol has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agudelo, C; Garovich, M; Pisko, E | 1 |
| Besch-Williford, CL; Keisler, DH; McMurray, RW; Walker, SE | 1 |
2 other study(ies) available for ethinyl estradiol and Bright Disease
| Article | Year |
|---|---|
Oral contraceptives and systemic lupus erythematosus.
Topics: Administration, Oral; Adolescent; Arthritis; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Fever; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic | 1980 |
Premature death with bladder outlet obstruction and hyperprolactinemia in New Zealand black X New Zealand white mice treated with ethinyl estradiol and 17 beta-estradiol.
Topics: Animals; Drug Implants; Estradiol; Ethinyl Estradiol; Glomerulonephritis; Hyperprolactinemia; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Mice; Mice, Mutant Strains; Pituitary Gland; Urinary Bladder; Urinary Bladder Neck Obstruction | 1992 |